Supplemental material
Emerging Microbes & Infections
Volume 13, 2024 - Issue 1
Open access
1,365
Views
0
CrossRef citations to date
0
Altmetric
Emerging and Re-Emerging Coronaviruses
Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies
Jing Lua State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;b Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China;c Center for mRNA Translational Research, Fudan University, Shanghai, People’s Republic of China;d Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Shudan Tana State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;b Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China;c Center for mRNA Translational Research, Fudan University, Shanghai, People’s Republic of China;d Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Hao Gud Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Kunpeng Liue State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of China;f University of the Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
, Wei Huangd Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Zhaoli Yud Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Guoliang Lua State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;b Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China;c Center for mRNA Translational Research, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Zihan Wua State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;b Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China;c Center for mRNA Translational Research, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Xiaobo Gaod Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Jinghua Zhaoa State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;b Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China;c Center for mRNA Translational Research, Fudan University, Shanghai, People’s Republic of China;d Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Zongting Yaod Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Feng Yid Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Yantao Yangd Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Hu Wangd Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Xue Hud Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Mingqing Lue State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of China;f University of the Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
, Wei Lia State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;b Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China;c Center for mRNA Translational Research, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Hui Zhoud Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Hang Yud Shanghai RNACure Biopharma Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Chao Shane State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of China;f University of the Chinese Academy of Sciences, Beijing, People’s Republic of China;g Hubei Jiangxia Laboratory, Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Jinzhong Lina State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;b Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China;c Center for mRNA Translational Research, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-5666-8526View further author information
show allhttps://orcid.org/0000-0001-5666-8526View further author information
Article: 2321994
|
Received 07 Nov 2023, Accepted 16 Feb 2024, Published online: 29 Feb 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.